Tissue-penetrating delivery of compounds and nanoparticles into tumors.
about
NRP1 function and targeting in neurovascular development and eye diseaseSystemically Administered, Target Organ-Specific Therapies for Regenerative MedicineThe TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeuticsMagnetic particle imaging (MPI) for NMR and MRI researchersBiosafe nanoscale pharmaceutical adjuvant materialsαV integrins in angiogenesis and cancerApproaches to improve tumor accumulation and interactions between monoclonal antibodies and immune cellsToward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challengesMultifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilitiesNeuropilins and liverPeptides as targeting probes against tumor vasculature for diagnosis and drug deliveryIsolation of rare tumor cells from blood cells with buoyant immuno-microbubblesLigand-based targeted therapy: a novel strategy for hepatocellular carcinomaExploring the tumor microenvironment with nanoparticlesPhage display discovery of novel molecular targets in glioblastoma-initiating cellsFurin targeted drug delivery for treatment of rhabdomyosarcoma in a mouse modelEfficient elimination of cancer cells by deoxyglucose-ABT-263/737 combination therapyPeripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in miceA tumor-penetrating peptide modification enhances the antitumor activity of thymosin alpha 1A Novel Strategy to Improve the Therapeutic Efficacy of Gemcitabine for Non-Small Cell Lung Cancer by the Tumor-Penetrating Peptide iRGDTumor-Specific Peptide, Selected from a Phage Peptide Library, Enhances Antitumor Activity of LactaptinReplication Study: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugsRegistered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugsEnhancing Tumor Penetration of Nanomedicines.Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAsIncreasing Tumor Accessibility with Conjugatable Disulfide-Bridged Tumor-Penetrating Peptides for Cancer Diagnosis and Treatment.The use of therapeutic peptides to target and to kill cancer cells.β₁Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapyDelivery of cancer therapeutics using nanotechnologyQuantity and accessibility for specific targeting of receptors in tumours.Selection of phage-displayed peptides on live adherent cells in microfluidic channels.Combinatorial peptide libraries: mining for cell-binding peptides.Novel target for peptide-based imaging and treatment of brain tumorsCo-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells.sTRAIL-iRGD is a promising therapeutic agent for gastric cancer treatmentQuantification of confocal images of biofilms grown on irregular surfacesThe effect of superparamagnetic iron oxide with iRGD peptide on the labeling of pancreatic cancer cells in vitro: a preliminary study.Targeting of drugs and nanoparticles to tumors.Peptide-mediated liposomal drug delivery system targeting tumor blood vessels in anticancer therapy.Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid-paclitaxel (CLA-PTX) on B16-F10 melanoma.
P2860
Q26765952-EC6B84EB-22C4-4920-88E0-A54F33BF16A8Q26782082-28B0B3D1-B63E-4D04-9736-49BA244662AEQ26795601-9064FF23-6699-47E1-B2C8-AFEF6AD232BAQ26827983-852E1090-066A-40A9-BB7B-6103835DA10FQ26829798-954CC45D-F468-4054-9436-639ECEDD8C48Q26851768-68816504-23CC-4776-BB73-FB0D4F378AE2Q26852287-25A168BF-4085-4F2F-B72B-799783FD7B6FQ26995399-C8F9F10D-AD9D-47AD-8FA0-BE8E91FA5B99Q27011598-93CD646C-CC0B-42C3-B35F-EC9DAEB95346Q27024032-4B859B2A-D8F5-45F5-88B2-164DF94F329CQ27024850-59F66956-83CD-461B-8AE3-DB3064D49F48Q27335994-A4FF4A57-4CDA-4CC8-AEB1-F977BE18FE76Q28068437-358A7CF8-842A-4923-8A4C-6D8B917AAD58Q28082374-6A914987-A9E5-4A84-BB45-558E3A45BB1AQ28240138-859928C7-0387-49B4-8E02-3C5320CAE44DQ28473831-28046619-8BE2-4A40-A89C-9307242FF78DQ28477131-294B1EA7-0C26-4E83-8329-2827FD780D15Q28486624-EDF4C555-E07B-4616-9712-CC02748AA8C3Q28535426-A56CE1CB-7600-46C2-AC74-8A5468905908Q28548244-BC8BD27A-5FEB-4236-936E-0C2A3437D6CDQ28553463-4ADA2A61-D710-4D45-A072-594A8115ADE8Q28559700-88413585-99A3-42A7-9309-06761DB2170EQ28647159-8B0FDB40-D4D3-4053-AA70-BB7728F7D932Q30356887-747FCBDB-AAC2-4D34-A912-462A483D3C0CQ30367369-E24E173E-4609-491B-9270-620FBDB9761CQ30379645-2BF05BF6-120E-4207-AB0C-2E12C2180E37Q30418414-FC056F15-B18B-4E10-9954-F7EE57058030Q30427521-A26CC9EE-45F8-4E80-A653-82F07E93048DQ30446963-D6ED3A63-5BE4-4216-9290-38CDCBEAC797Q30580276-C1046088-C3D1-41A6-B475-222CDC1DB74BQ31004986-457889EC-B17F-439F-8365-3EBDBA843CDDQ31144876-120ACF71-5582-491B-ABB7-DCF0F2DC1030Q33554409-C3A53107-E7E1-49EE-AABE-CE5098F31F66Q33634653-8B0BE52C-92FE-46DA-9F3E-FE02651A21A9Q33674412-889F2057-5C4B-4543-8084-B8509D8116BCQ33697147-567BC5C6-31AB-4AFC-8FFA-62C22F0DFFA6Q33746572-71339179-F121-464C-81F6-3DB661904BBCQ33751710-1CA5EFFF-0589-483A-8266-D25F79AD9974Q33829569-F9C4EB07-0DA5-4E76-AEFF-A8BB6065C86DQ33830347-99975EC9-DE4B-413D-9B91-E767264E2596
P2860
Tissue-penetrating delivery of compounds and nanoparticles into tumors.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Tissue-penetrating delivery of compounds and nanoparticles into tumors.
@ast
Tissue-penetrating delivery of compounds and nanoparticles into tumors.
@en
type
label
Tissue-penetrating delivery of compounds and nanoparticles into tumors.
@ast
Tissue-penetrating delivery of compounds and nanoparticles into tumors.
@en
prefLabel
Tissue-penetrating delivery of compounds and nanoparticles into tumors.
@ast
Tissue-penetrating delivery of compounds and nanoparticles into tumors.
@en
P2093
P2860
P1433
P1476
Tissue-penetrating delivery of compounds and nanoparticles into tumors.
@en
P2093
Kazuki N Sugahara
Lilach Agemy
Olivier M Girard
Priya Prakash Karmali
Robert F Mattrey
Tambet Teesalu
Venkata Ramana Kotamraju
P2860
P304
P356
10.1016/J.CCR.2009.10.013
P577
2009-12-01T00:00:00Z